OPPI Celebrates its 50th Year Jubilee
The Organisation of Pharmaceutical Producers of India (OPPI) represents the research-based pharmaceutical companies in India. OPPI celebrated its 50th year with all healthcare stakeholders, looking back at a memorable half century and renewing its commitment to bringing quality medicines to patients across the nation. In his inaugural address, Shri. Ch. Vidyasagar Rao, Hon'ble Governor of Maharashtra, said, "I have come here to express my sense of appreciation to the OPPI and to the captains of the pharmaceutical industry for your outstanding contributions to the cause of nation building." The Governor stressed on India's tremendous strength in life sciences, specifically in innovative medicines and the country's rich human capital, including chemists, pharmacists, biologists and engineers. "The research-based pharmaceutical industry in India has long been a partner in India's economic growth and development, including through technical collaborations, disease awareness programs, patient access initiatives and drug safety efforts. At this juncture, we need to have a renewed thrust on innovation from the pharmaceutical industry in India," he added.
Dignitaries including Dr. V K Subbaraj, Secretary, Department of Pharmaceuticals and Dr Jagdish Prasad, Director General of Health Services were present on the occasion celebrating the '50 Years theme: Healthy India, Innovative India'.
Highlighting the role played by OPPI in its 50 year journey, Dr. Shailesh Ayyangar, President, OPPI said, "OPPI has been at the forefront in developing the nation's pharmaceutical industry for the past 50 years. We have consistently supported Government's healthcare agenda and have been a dedicated partner in India's journey of developing a robust pharmaceutical industry, which is recognised world-over."
In a recorded message, Shri Devendra Fadnavis, Hon'ble Chief Minister of Maharashtra, commended the good work of the pharma companies, while assuring the industry of a conducive business environment for sustained growth.
An eminent panel of OPPI's Office Bearers decided to confer Special Golden Jubilee recognitions to mark its 50 years:
The day saw two animated panel discussions. The first on healthcare innovation in India focused on the sort of innovations that can transform the healthcare landscape in India. The second, patient group discussion, touched upon the important role that pharmaceutical companies must play to improve the lives of patients and support responsible healthcare.
Dignitaries including Dr. V K Subbaraj, Secretary, Department of Pharmaceuticals and Dr Jagdish Prasad, Director General of Health Services were present on the occasion celebrating the '50 Years theme: Healthy India, Innovative India'.
Highlighting the role played by OPPI in its 50 year journey, Dr. Shailesh Ayyangar, President, OPPI said, "OPPI has been at the forefront in developing the nation's pharmaceutical industry for the past 50 years. We have consistently supported Government's healthcare agenda and have been a dedicated partner in India's journey of developing a robust pharmaceutical industry, which is recognised world-over."
In a recorded message, Shri Devendra Fadnavis, Hon'ble Chief Minister of Maharashtra, commended the good work of the pharma companies, while assuring the industry of a conducive business environment for sustained growth.
An eminent panel of OPPI's Office Bearers decided to confer Special Golden Jubilee recognitions to mark its 50 years:
- Dr Prathap C Reddy, Founder Chairman, Apollo Hospitals Group: Lifetime Achievement-Contribution to Modern healthcare
- D.B. Gupta, Founder and Chairman, Lupin Ltd: Lifetime Achievement in the pharmaceutical industry
- Dr Tarun Gupta, Professor Emeritus, NMIMS: Advancement of education in pharmaceuticals
- Dr J.N. Banerjee: Founding member of OPPI
- Prof R.D. Joshi, former Secretary General, OPPI: Meritorious commitment to OPPI
- Ranjit Shahani, Vice Chairman and Managing Director, Novartis: President Emeritus, OPPI.
The day saw two animated panel discussions. The first on healthcare innovation in India focused on the sort of innovations that can transform the healthcare landscape in India. The second, patient group discussion, touched upon the important role that pharmaceutical companies must play to improve the lives of patients and support responsible healthcare.
Next Story